XML 25 R13.htm IDEA: XBRL DOCUMENT
v3.24.2

STOCKHOLDERS' EQUITY AND EARNINGS PER SHARE | 6 Months Ended
--- | ---
Jun. 30, 2024
STOCKHOLDERS' EQUITY AND EARNINGS PER SHARE |
STOCKHOLDERS' EQUITY AND EARNINGS PER SHARE | NOTE 5. STOCKHOLDERS’ EQUITY AND EARNINGS PER SHARE Accumulated Other Comprehensive Income (Loss) The following table summarizes the components of, and changes in, accumulated other comprehensive income (loss), net of income taxes. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | Foreign Currency Translation |  | ​ | Change in Fair Value of Cash Flow Hedges |  | ​ | Defined Employee Benefit Plan |  | ​ | Total
Balance at December 31, 2022 | ​ | $ | (12,823) | ​ | $ | 11,848 | ​ | $ | 17,295 | ​ | $ | 16,320
Other comprehensive income (loss) prior to reclassifications | ​ | ​ | (196) | ​ | ​ | 595 | ​ | ​ | — | ​ | ​ | 399
Amounts reclassified from accumulated other comprehensive income (loss) | ​ | ​ | — | ​ | ​ | (2,412) | ​ | ​ | — | ​ | ​ | (2,412)
Balance at March 31, 2023 | ​ | ​ | (13,019) | ​ | ​ | 10,031 | ​ | ​ | 17,295 | ​ | ​ | 14,307
Other comprehensive income (loss) prior to reclassifications | ​ | ​ | (1,533) | ​ | ​ | 2,555 | ​ | ​ | — | ​ | ​ | 1,022
Amounts reclassified from accumulated other comprehensive income (loss) | ​ | ​ | — | ​ | ​ | (2,756) | ​ | ​ | (292) | ​ | ​ | (3,048)
Balance at June 30, 2023 | ​ | $ | (14,552) | ​ | $ | 9,830 | ​ | $ | 17,003 | ​ | $ | 12,281
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ | Foreign Currency Translation |  | ​ | Change in Fair Value of Cash Flow Hedges |  | ​ | Defined Employee Benefit Plan |  | ​ | Total
Balance at December 31, 2023 | ​ | $ | (10,796) | ​ | $ | 5,474 | ​ | $ | 11,436 | ​ | $ | 6,114
Other comprehensive income (loss) prior to reclassifications | ​ | ​ | (6,589) | ​ | ​ | 1,405 | ​ | ​ | — | ​ | ​ | (5,184)
Amounts reclassified from accumulated other comprehensive income (loss) | ​ | ​ | — | ​ | ​ | (2,785) | ​ | ​ | — | ​ | ​ | (2,785)
Balance at March 31, 2024 | ​ | ​ | (17,385) | ​ | ​ | 4,094 | ​ | ​ | 11,436 | ​ | ​ | (1,855)
Other comprehensive income (loss) prior to reclassifications | ​ | ​ | (2,561) | ​ | ​ | 395 | ​ | ​ | — | ​ | ​ | (2,166)
Amounts reclassified from accumulated other comprehensive income (loss) | ​ | ​ | — | ​ | ​ | (2,751) | ​ | ​ | (51) | ​ | ​ | (2,802)
Balance at June 30, 2024 | ​ | $ | (19,946) | ​ | $ | 1,738 | ​ | $ | 11,385 | ​ | $ | (6,823)
​ Amounts reclassified from accumulated other comprehensive income (loss) to the specific caption within the Consolidated Statements of Operations were as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, |  | Six Months Ended June 30, |  | To Caption on Consolidated
​ |  | 2024 | ​ | 2023 | ​ |  | 2024 |  | ​ | 2023 | ​ | Statements of Operations
Cash flow hedges | ​ | $ | (2,751) | ​ | $ | (2,756) | ​ | $ | (5,536) | ​ | $ | (5,168) | ​ | Interest expense
Defined employee benefit plan | ​ | ​ | (51) | ​ | ​ | (292) | ​ | ​ | (51) | ​ | ​ | (292) | ​ | Other income (expense), net
Total reclassifications | ​ | $ | (2,802) | ​ | $ | (3,048) | ​ | $ | (5,587) | ​ | $ | (5,460) | ​ | ​
​ Earnings Per Share The following table summarizes our earnings per share (“EPS”): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ |  | 2024 |  | 2023 |  | 2024 |  | 2023
Income from continuing operations | ​ | $ | 15,604 | ​ | $ | 27,455 | ​ | $ | 21,391 | ​ | $ | 59,207
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Basic weighted-average common shares outstanding | ​ |  | 37,474 | ​ |  | 37,573 | ​ |  | 37,417 | ​ |  | 37,524
Dilutive effect of stock awards | ​ |  | 303 | ​ |  | 230 | ​ |  | 316 | ​ |  | 280
Diluted weighted-average common shares outstanding | ​ |  | 37,777 | ​ |  | 37,803 | ​ |  | 37,733 | ​ |  | 37,804
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
EPS from continuing operations | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Basic EPS | ​ | $ | 0.42 | ​ | $ | 0.73 | ​ | $ | 0.57 | ​ | $ | 1.58
Diluted EPS | ​ | $ | 0.41 | ​ | $ | 0.73 | ​ | $ | 0.57 | ​ | $ | 1.57
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Anti-dilutive shares not included above | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Stock awards | ​ | ​ | — | ​ | ​ | 144 | ​ | ​ | 55 | ​ | ​ | 121
Warrants | ​ | ​ | 3,166 | ​ | ​ | — | ​ | ​ | 3,183 | ​ | ​ | —
Total anti-dilutive shares | ​ | ​ | 3,166 | ​ | ​ | 144 | ​ | ​ | 3,238 | ​ | ​ | 121
​ We compute basic earnings per share of common stock (“Basic EPS”) by dividing income available to common stockholders by the weighted-average number of common shares outstanding during the period. ​ See Note 18. Long-Term Debt in our Annual Report on Form 10-K for the year ended December 31, 2023 for information regarding our Convertible Notes, Note Hedges, and Warrants. For diluted earnings per share of common stock (“Diluted EPS”), we increase the weighted-average number of common shares outstanding during the period, as needed, to include the following:
| ● | Additional common shares that would have been outstanding if our outstanding stock awards had been converted to common shares using the treasury stock method. We exclude any stock awards that have an anti-dilutive effect;
| ● | Dilutive impact associated with the Convertible Notes using the if-converted method. The Convertible Notes are repayable in cash up to par value and in cash or shares of common stock for the excess over par value. When the stock price is lower than the strike price, there is no dilutive or anti-dilutive impact. Prior to conversion, we do not consider the Note Hedges for purposes of Diluted EPS as their effect would be anti-dilutive. Upon conversion, we expect the Note Hedges to offset the dilutive effect of the Convertible Notes when the stock price is above $137.46 but below $179.76; and
| ● | Dilutive effect of the Warrants issued concurrently with the Convertible Notes using the treasury stock method. For all periods presented, the Warrants did not increase the weighted-average number of common shares outstanding because the $179.76 exercise price of the Warrants exceeded the average market price of our common stock.
Share Repurchase At June 30, 2024, the remaining amount authorized by the Board of Directors for future share repurchases was $199.2 million with no time limitation. There were no share repurchases during any periods presented.

X
- References No definition available. + Details
Name: | aeis_EquityAndEarningPerShareAbstract
Namespace Prefix: | aeis_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for equity and earnings per share. + References No definition available. + Details
Name: | aeis_EquityAndEarningsPerShareTextBlock
Namespace Prefix: | aeis_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration